A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
Clinical trial NCT04537923 · COMPLETED
Trial details
- NCT number
- NCT04537923
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2022-10-11
- Enrollment
- 1428
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.